Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 16, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
21,000
Total Value
$273,944.45
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 3,500 | $6.84 | $23,940.00 | 5,018 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 15, 2026 | Exercise/Conversion | 3,500 | $7.80 | $27,300.00 | 8,518 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 15, 2026 | Sale | 4,381 | $31.56 | $138,275.75 | 4,137 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 15, 2026 | Sale | 2,619 | $32.24 | $84,428.70 | 1,518 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | Jan 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 221,563 | Direct | โ | View Details | |
Chief Medical Officer | Employee Warrant (right to buy) | Derivative | Jan 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 192,992 | Direct | โ | View Details |